STAAR Surgical Company logo STAA - STAAR Surgical Company

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 10
SELL 1
STRONG
SELL
0
| PRICE TARGET: $29.33 DETAILS
HIGH: $40.00
LOW: $13.00
MEDIAN: $31.50
CONSENSUS: $29.33
UPSIDE: 4.19%

About STAAR Surgical Company (https://www.staar.com)

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.

Key Executives

NAME TITLE DOB SALARY
Warren Foust Interim Co-CEO, President & COO 1977 $1,440,648 USD
Deborah J. Andrews Interim Co-CEO & CFO 1957 $1,182,395 USD
Magda Michna Chief Development Officer $895,716 USD
Scott D. Barnes Chief Medical Officer 1963 $691,149 USD
Connie Johnson Director of Investor Relations
Filip De Keersmaecker Senior Vice President of Global E2E Supply Chain
Kathleen Determann VP, Deputy General Counsel and Chief Compliance & Privacy Officer
Nancy Sabin Chief Marketing Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.